Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha [Yahoo! Finance]
Daxor Corporation - Closed End Fund (DXR)
NASDAQ:AMEX Investor Relations:
daxor.com/investors
Company Research
Source: Yahoo! Finance
beginning deployments while pursuing a “ razor-and-blades ” commercial model that drives recurring revenue from its Volumex test kits rather than instrument sales. The company points to clinical adoption and reimbursement—more than 75,000 tests shipped, 170 peer-reviewed studies, CPT/APC coding and insurer coverage—and cited a JACC: Heart Failure study reporting large reductions in readmissions and mortality when care was guided by blood volume analysis. Daxor operates a vertically integrated 20,000 sq ft Oak Ridge facility with capacity for up to 200,000 test kits annually, plans to bring a key supplier fully in-house (adding a second drug, Glofil), and reported a 45% FY2025 revenue increase, a $9 million January capital raise, no debt, and roughly $66 million market cap. Interested in Daxor Corporation? Here are five stocks we like better. Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus o
Show less
Read more
Impact Snapshot
Event Time:
DXR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXR alerts
High impacting Daxor Corporation - Closed End Fund news events
Weekly update
A roundup of the hottest topics
DXR
News
- Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript [Seeking Alpha]Seeking Alpha
- Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress [Yahoo! Finance]Yahoo! Finance
- Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care CongressGlobeNewswire
- Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 [Yahoo! Finance]Yahoo! Finance
- Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026GlobeNewswire
DXR
Sec Filings
- 3/2/26 - Form N-CSR
- 3/2/26 - Form NPORT-P
- 2/9/26 - Form 40-8F-2
- DXR's page on the SEC website